6505--Hydralazine HCL Injections Award - Hikma Pharmaceuticals

Award Notice Posted

A later notice was posted: the Limited / Sole Source Justification from .

Solicitation number
36E79725R0048
Agency
Awarded
to Hikma Pharmaceuticals USA Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36E79726D0001 Federal IDV award
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Department of Veterans Affairs National Acquisition Center awarded contract 36E79726D0001 to Hikma Pharmaceuticals USA Inc. on November 21, 2025, for the supply of Hydralazine HCL Injections with a contract value of $2,371,481.00. Hydralazine HCL is a pharmaceutical product classified under Product Service Code 6505 and NAICS Code 325412, indicating pharmaceutical preparation manufacturing and distribution. The contract was issued under solicitation number 36E79725R0048 with no set-aside provisions applied. While the specific quantity of injections or delivery timeline is not detailed in the available award documentation, the substantial contract value indicates a significant procurement of this injectable medication to support VA healthcare operations. The point of contact for this award is Nicholas McGregor at the VA National Acquisition Center.

Notice text

Awarded contract 36E79726D0001 to HIKMA PHARMACEUTICALS USA INC. for 2371481.00 on 2025-11-21.

Files

File Type Posted
36E79726D0001.docx DOCX document

Notice history

Notice Type Posted
6505--Hydralazine HCL Injections Award - Hikma Pharmaceuticals Latest Limited / Sole Source Justification
This notice Award Award Notice
6505--Hydralazine Injection Latest solicitation Solicitation
6505--Hydralazine Injection Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login

GovTribe for Federal Contractors